Good find.
I had never heard of Royalty Pharma.
It sounds like factoring, except for a stream of payments rather than for a single payment
So another option for RAC is to partner and then sell part or all of the agreed future royalties to Royalty Pharma.
Ann: Expanded Heart Protection Discovery for Zantrene, page-191
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.78 |
Change
-0.085(4.56%) |
Mkt cap ! $315.0M | |||
| Open | High | Low | Value | Volume |
| $1.86 | $1.86 | $1.76 | $298.5K | 164.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2853 | $1.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.78 | 1200 | 1 |
View Market Depth
| Last trade - 15.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.78 |
Change
-0.085 ( 5.38 %) |
||||
| Open | High | Low | Volume | ||
| $1.81 | $1.86 | $1.76 | 25093 | ||
| Last updated 15.35pm 14/06/2024 ? | |||||
| RAC (ASX) Chart |